Grant Will Address Congestive Heart Failure

Main Category: Heart Disease
Also Included In: Cardiovascular / Cardiology;  Biology / Biochemistry;  Preventive Medicine
Article Date: 21 Dec 2010 - 0:00 PDT

Current ratings for:
'Grant Will Address Congestive Heart Failure'

Patient / Public:5 stars

5 (1 votes)

Healthcare Prof:not yet rated


A grant of about $1.8 million over five years will help scientists better understand congestive heart failure, a condition that affects 5.7 million Americans annually.

John Robinson, a medical doctor and biophysicist at South Dakota State University, has been awarded the funding by the Heart, Lung and Blood Institute of the National Institutes of Health. The research could supply new knowledge about heart failure that could lead to new treatment strategies.

The risk of congestive heart failure increases sharply with age, doubling every 10 years among older adults. At younger ages, blacks are disproportionately affected compared to whites by a ratio of 20 to 1.

Robinson, a member of the Department of Chemistry and Biochemistry in SDSU's College of Arts and Sciences, is especially interested in heart failure in connection with impaired function of the myofilament, a protein assembly regulated by calcium that makes the heart contract.

"The myofilament is the fundamental unit that allows the heart to generate force. Your heart has to beat and relax about once every second," Robinson said. "These periods of contraction and relaxation are regulated by the levels of calcium inside cells of the heart. The myofilament is a calcium-sensitive switch that generates force when calcium binds to it."

However, scientists don't fully understand how the myofilament functions or what goes wrong when it doesn't work properly. Robinson said that's because those processes are taking place at the nanoscale, or roughly at a level 100 to 1,000 times smaller than can be seen by using a conventional microscope.

"Switching in the nanoscale is very different from switching in our world. If I turn a light switch on, it stays on," Robinson said. "What we're seeing with protein switches is that just because calcium binds to it, it will not necessarily turn on. It's sort of error-prone. All of the switching is done by heat random collisions with water is what drives all of this."

Robinson said a revolution in instrumentation is making it possible to unravel such processes, some of which have been studied for decades. Robinson is part of the SDSU-based Center for Biological Control and Analysis by Applied Photonics, or BCAAP. The center is made up of researchers who use light as one of the tools either to control biochemical processes or, in this case, to analyze biochemical processes.

Robinson's laboratory uses a technique called Fluorescence Resonance Energy Transfer, or FRET, to study proteins at the nanoscale. His FRET measurements are at the "single molecule" level, studying myofilaments one at a time.

Robinson's five-year NIH project will work to establish what molecular interactions are taking place as the myofilament contracts; and to understand the mechanisms at work when myofilaments' sensitivity to calcium is altered.

Source: South Dakota State University

Article adapted by Medical News Today from original press release.
Visit our heart disease section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
South Dakota State University. "Grant Will Address Congestive Heart Failure." Medical News Today. MediLexicon, Intl., 21 Dec. 2010. Web.
25 May. 2012. <http://www.medicalnewstoday.com/releases/211975.php>

APA
South Dakota State University. (2010, December 21). "Grant Will Address Congestive Heart Failure." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/211975.php.

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'Grant Will Address Congestive Heart Failure'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Your Name:*
E-mail Address:*
Your Opinion Title:*
Opinion:*
This is to help prevent SPAM submissions. Please enter the words exactly as they appear, including capital letters and punctuation.*

* Fields marked with a * need to be filled in before you hit the submit button.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


Heart Disease

What is Atrial Fibrillation?

The human heart has two upper chambers and two lower chambers. The upper chambers are called the left atrium and the right atrium - the plural of atrium is atria. The two lower chambers are the the left ventricle and the right ventricle. Read more...

Most Popular Articles



Follow Our Heart Disease News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Heart Disease Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »